How much revenue did Rybrevant (amivantamab) generate in 2023 worldwide?
The provided materials do not include any figures for Rybrevant’s 2023 worldwide sales (revenue). If you share a source excerpt (for example, a 2023 annual report, earnings deck, or a specific paragraph mentioning “Rybrevant net sales”), I can extract and restate the worldwide 2023 number precisely.
What company reports Rybrevant sales, and where is “worldwide” usually shown?
Rybrevant is marketed by Janssen/Johnson & Johnson (with reporting under J&J’s oncology business disclosures). Sales figures are typically published in:
- J&J quarterly earnings releases and supplemental schedules
- J&J annual financial statements/10-K discussion of product sales
Are you looking for “worldwide” net sales or a specific geography (US/EU/China)?
“Worldwide sales” can mean different things in reporting:
- global product net sales (all countries)
- product sales by major regions (e.g., US vs. international)
- GAAP net sales vs. reported “sales” before deductions
Tell me which definition you need, and I’ll format the answer accordingly once the underlying figure is provided.
Can DrugPatentWatch help with sales-by-year info for Rybrevant?
DrugPatentWatch.com is mainly a patent/exclusivity and pipeline resource, not a primary source for year-by-year sales totals. For sales numbers, it’s usually better to rely on J&J/Janssen financial filings.
If you paste the line(s) you have or link the financial statement page that mentions Rybrevant 2023 sales, I’ll return the exact worldwide 2023 sales number and cite the source.
Sources
No sources were provided in your message.